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The key point about aspartame is that very little is consumed. Because it is 180 times sweeter than sugar, relatively little shows up in products. For example, a 355 ml can of diet soda contains 180 mg of aspartame, which for a 70 kg human is a 2.5 mg kg À1 dose (1.25 mg kg À1 phenylalanine). After its introduction, its use was monitored for years, revealing that average daily dosing is barely 5 mg kg À1 day
À1
(2.5 mg kg À1 day À1 phenylalanine), not much. As a comparison, the amount of phenylalanine in a quarter-pound hamburger is about 1000 mg, or 14 mg kg À1 phenylalanine (70 kg individual), or much more. It is important to keep this fact in mind when considering the authors' arguments, which relate to studies in animals involving extremely high aspartame doses (for example, up to 2000 mg kg À1 in rats, a huge dose). Such studies have no relevance to human use. And, for aspartame to have effects in animals, blood levels of aspartame constituents (aspartate, phenylalanine, methanol) must increase to very high values. At the levels ingested by humans, such increases in blood do not occur, even at high levels of intake (Butchko et al., 2002; Magnuson et al., 2007) . The errors in this article are too numerous to enumerate in a letter of limited length. I note those most obvious to me. (a) Formate is not converted to diketopiperazine (abstract). (b) The authors are incorrect in stating that tyrosine cannot be synthesized in brain from phenylalanine. (c) Despite the authors' statement, even very large increases in phenylalanine levels produced by aspartame administration to rats do not suppress catecholamine synthesis rate (Fernstrom et al., 1991) . (d) , a huge dose. And their results could not be confirmed (see Butchko et al., 2002; Magnuson et al., 2007) . (f) Aspartame does not enter the blood from the gut, and thus does not get into brain. Hence, brain glutamate receptors cannot be engaged directly by aspartame, despite the authors' assertions. (g) Despite the authors' statement, my 1994 Journal of the American Dietetic Association article does not state that aspartame increases brain levels of acidic amino acids. (h) There is no such thing as 'excitotoxicsaturated placental blood flow' caused by maternal aspartame consumption. (i) Finally, many erroneous statements have been obtained from two websites, one cited as MehlMadrona and the other as Bowen and Evangelista. These seem to me to be inappropriate references, as their contents have not been subjected to peer review, and contain unsupported speculation.
While I recognize the need for a continuing dialog on any issue relevant to human nutrition and health, here in relation to aspartame, in my view, the article by Humphries does not make an informed contribution. A consideration of the likely error of underreporting in participants And the fact that 'low' plasma zinc concentration was only detected in a very small minority of participants
JD Fernstrom
We would like to offer a different interpretation of these results for the reasons set out below:
(a) Although the problem of underreporting was previously reported in this survey, the impact of the error was not considered to be high enough to alter the major findings of the survey. (b) The feasibility study of this National Diet and Nutrition Survey, including estimates of energy expenditure using the 'doubly labelled water' technique, indicated that there was sufficient validity for adopting the methodology for the main stage survey (Gregory et al., 2000) . (c) Plasma zinc is generally considered to be a poor measure of marginal zinc deficiency, as the level of zinc in plasma is homeostatically controlled and, in marginal zinc deficiency, may remain within the normal range. (d) Several confounding factors can affect plasma zinc levels. For instance, plasma zinc concentration may vary according to time of the day, proximity of meals,
